(Q38062822)

28 August 2017

1 reference

title

Intravesical treatments of bladder pain syndrome/interstitial cystitis (English)

1 reference

28 August 2017

Jochen Neuhaus

1

1 reference

28 August 2017

Thilo Schwalenberg

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

27 November 2012

1 reference

28 August 2017

Nature Reviews Urology

1 reference

28 August 2017

9

1 reference

28 August 2017

12

1 reference

28 August 2017

707-720

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2012.217

28 August 2017

0 references

cites work

The prevalence of urinary incontinence in women in four European countries

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Urgency: the key to defining the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The complexity of chronic pelvic pain exemplified by the condition currently called interstitial cystitis. Part 1: Background and basic principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Urine markers of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Bladder pain syndrome/interstitial cystitis in a Danish population: a study using the 2008 criteria of the European Society for the Study of Interstitial Cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Role of gap junctions in spontaneous activity of the rat bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Changes of gap junctional cell-cell communication in overactive detrusor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Connexins 43 and 26 are differentially increased after rat bladder outlet obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Connexin26 is regulated in rat urothelium by the scaffold protein IB1/JIP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The function of suburothelial myofibroblasts in the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Connexin 26 is abnormally expressed in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

[Gap junctions in the human urinary bladder]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Alterations in connexin expression in the bladder of patients with urge symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A gap junction blocker inhibits isolated whole bladder activity in normal rats and rats with partial bladder outlet obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Increased connexin43-mediated intercellular communication in a rat model of bladder overactivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Tonabersat, a novel gap-junction modulator for the prevention of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Expression and distribution of cholinergic receptors in the human urothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Uroplakins in urothelial biology, function, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Regulatory mechanisms in stem cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Epigenetic reprogramming: a possible etiological factor in bladder pain syndrome/interstitial cystitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Neural control of the lower urinary tract: peripheral and spinal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Sensory collaterals, intramural ganglia and motor nerves in the guinea-pig bladder: evidence for intramural neural circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Mechanotransduction and chemosensitivity of two major classes of bladder afferents with endings in the vicinity to the urothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The neural control of micturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Interstitial cells in the urinary bladder--localization and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Morphological expression of KIT positive interstitial cells of Cajal in human bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Characterization of upper lamina propria interstitial cells in bladders from patients with neurogenic detrusor overactivity and bladder pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The role of the human bladder lamina propria myofibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Regulation of connexin 43 by basic fibroblast growth factor in the bladder: transcriptional and behavioral implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Mucosal muscarinic receptors enhance bladder activity in cats with feline interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

ATP enhances spontaneous calcium activity in cultured suburothelial myofibroblasts of the human bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Structural basis of neurogenic bladder dysfunction. II. Myogenic basis of detrusor hyperreflexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Urinary potassium and the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

SNAP receptors implicated in vesicle targeting and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The influence of botulinum toxin type A (BTX) on the immunohistochemical characteristics of noradrenergic and cholinergic nerve fibers supplying the porcine urinary bladder wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Evidence that botulinum toxin receptors on epithelial cells and neuronal cells are not identical: implications for development of a non-neurotropic vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical botulinum toxin type A in chronic interstitial cystitis: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of the contractile apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Risk factors that affect the treatment of interstitial cystitis using intravesical therapy with a dimethyl sulfoxide cocktail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Contemporary management of the painful bladder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Results of endovesical hyaluronic acid/chondroitin sulfate in the treatment of Interstitial Cystitis/Painful Bladder Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Grading the severity of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A global measure of perceived stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Botulinum A toxin intravesical injections for painful bladder syndrome: impact upon pain, psychological functioning and Quality of Life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The Use of Dimethyl-Sulfoxide (DMSO) in the Treatment of Interstitial Cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Inhibition of stretching-evoked ATP release from bladder mucosa by anticholinergic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Epidemiology of interstitial cystitis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

EAU guidelines on chronic pelvic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Clinical features and spectrum of light microscopic changes in interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Fine-structural evidence for vascular injury in patients with interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Increased Cannabinoid Receptor 1-Immunoreactive Nerve Fibers in Overactive and Painful Bladder Disorders and Their Correlation With Symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Nerve fibre proliferation in interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Identification of proteoglycans present at high density on bovine and human bladder luminal surface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Increased expression of connexin 43 in the overactive neurogenic detrusor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--a possible sensory mechanism?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Acetylcholine and molecular components of its synthesis and release machinery in the urothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intramural ganglia of the human urinary bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

JTS-653 blocks afferent nerve firing and attenuates bladder overactivity without affecting normal voiding function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Gap junctions and connexin expression in human suburothelial interstitial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Localization of M 2 and M 3 Muscarinic Receptors in Human Bladder Disorders and Their Clinical Correlations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

TGF-beta1 inhibits Cx43 expression and formation of functional syncytia in cultured smooth muscle cells from human detrusor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans--a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The Use of Dimethyl Sulfoxide (DMSO) in the Treatment of Interstitial Cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A controlled study of dimethyl sulfoxide in interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The interstitial cystitis symptom index and problem index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Did Patients With Interstitial Cystitis Who Failed to Respond to Initial Treatment With Bacillus Calmette-Guerin or Placebo in a Randomized Clinical Trial Benefit From a Second Course of Open Label Bacillus Calmette-Guerin?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

PENTOSANPOLYSULFATE INHIBITS MAST CELL HISTAMINE SECRETION AND INTRACELLULAR CALCIUM ION LEVELS:: AN ALTERNATIVE EXPLANATION OF ITS BENEFICIAL EFFECT IN INTERSTITIAL CYSTITIS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Hyperbaric oxygen for the treatment of interstitial cystitis: long-term results of a prospective pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Bladder microvasculature in women with interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Impaired bladder perfusion in interstitial cystitis: a study of blood supply using laser Doppler flowmetry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

[Management of hemorrhagic radiation cystitis with hyperbaric oxygen therapy]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Self-administration of dimethyl sulfoxide (DMSO) for interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Hyaluronan treatment of interstitial cystitis/painful bladder syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: preliminary results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

The potassium sensitivity test: a predictor of treatment response in interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.217

Evidence of gap junctions in the stable nonobstructed human bladder

31 March 2020

1 reference

12 December 2020

Severe cyclophosphamide-induced haemorrhagic cystitis treated with hyperbaric oxygen

1 reference

12 December 2020

Smooth muscle cells from human urinary bladder express connexin 43 in vivo and in vitro

1 reference

12 December 2020

Use of DMSO for unapproved indications

1 reference

12 December 2020

The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study

1 reference

12 December 2020

Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987

1 reference

12 December 2020

Painful bladder syndrome: management and effect on sexual function and quality of life.

1 reference

12 December 2020

Clean intermittent self-catheterization in neuro-urology

1 reference

12 December 2020

Further experience with intravesical dimethyl sulfoxide in the treatment of interstitial cystitis

1 reference

12 December 2020

The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network

1 reference

12 December 2020

Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results

1 reference

12 December 2020

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

12 December 2020

Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

1 reference

12 December 2020

Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients

1 reference

12 December 2020

Medical use of dimethyl sulfoxide (DMSO).

1 reference

12 December 2020

Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis

1 reference

12 December 2020

The fine structure of autonomic neurons in the wall of the human urinary bladder.

1 reference

12 December 2020

Urinary symptoms and incontinence in women: relationships between occurrence, age, and perceived impact

1 reference

12 December 2020

The treatment of patients with interstitial cystitis, with special reference to intravesical DMSO

1 reference

12 December 2020

Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis

1 reference

12 December 2020

The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2012.217

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference